Ovid Therapeutics
OVID
OVID
69 hedge funds and large institutions have $135M invested in Ovid Therapeutics in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
+9
Holders Change %
+15%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
23
Increased
21
Reduced
15
Closed
14
Calls
$116K
Puts
$5K
Net Calls
+$111K
Net Calls Change
+$87K
Top Buyers
1 |
BlackRock
New York
|
+$8.8M |
2 |
State Street
Boston,
Massachusetts
|
+$2.74M |
3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.34M |
4 |
Northern Trust
Chicago,
Illinois
|
+$1.22M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$947K |